Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q2 FY21 results · Jul–Sep 2020
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,009.45 crore (up 18.5% from Q2 FY20) and net profit of ₹253.86 crore (up 85.5% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a standalone basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,009.45 | 852.14 | +18.5% | 634.53 | +59.1% |
| Other income | 9.56 | 11.02 | −13.2% | 9.55 | +0.1% |
| Total income | 1,019.01 | 863.16 | +18.1% | 644.08 | +58.2% |
| Profit before tax | 335.70 | 181.38 | +85.1% | 105.62 | +217.8% |
| Net profit for the period | 253.86 | 136.84 | +85.5% | 69.21 | +266.8% |
| EPS, basic (₹) | 78.21 | 42.16 | +85.5% | 21.32 | +266.8% |
| Net margin (%) | 25.1 | 16.1 | 10.9 |
Standalone
- Filed with BSE
- 10 Nov 2020, 19:46 IST
- Board meeting
- 10 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE